About this trial
This study will describe the transcriptomic and phenotypic characteristics of anti-HLA memory B cells by comparing five groups of patients awaiting renal transplantation: patients with a single history of pregnancy, transfusion or failure of a first renal transplant requiring transplantectomy within 3 months of transplantation, or after 3 months, and patients without an immunizing allogeneic event. The hypothesis is that these five contexts induce different types of memory B cells with different modalities of reactivation and post-transplant pathogenicity.
Eligibility criteria
Qualifiers
Adult kidney transplantation candidate at CHU de Bordeaux
Sensitized against class I HLA
Only on type of sensitizing event among : transfusion, pregnancy, previous transplantation, no senitizing event
Disqualifiers
Pediatric kidney transplantation candidate at CHU de Bordeaux
Rituximab injection
Ongoing treatment with immunosuppressive drugs
Non-cutaneous carcinoma, chronic viral infection
Trial design
Treatments tested in this trial
- Identification of types of anti-HLA-specific memory LBs